T. Rowe Price Associates’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
|
|||||
|
2025
Q1 | $1.97M | Sell |
|
|||||
|
2024
Q4 | $1.95M | Sell |
|
|||||
|
2024
Q3 | $2.64M | Sell |
|
|||||
|
2024
Q2 | $4.51M | Sell |
|
|||||
|
2024
Q1 | $3.01M | Sell |
|
|||||
|
2023
Q4 | $5.68M | Sell |
|
|||||
|
2023
Q3 | $5.45M | Sell |
|
|||||
|
2023
Q2 | $4.53M | Sell |
|
|||||
|
2023
Q1 | $13.3M | Sell |
|
|||||
|
2022
Q4 | $6.85M | Sell |
|
|||||
|
2022
Q3 | $7.18M | Sell |
|
|||||
|
2022
Q2 | $7.24M | Sell |
|
|||||
|
2022
Q1 | $7.87M | Sell |
|
|||||
|
2021
Q4 | $7.99M | Sell |
|
|||||
|
2021
Q3 | $7.99M | Sell |
|
|||||
|
2021
Q2 | $8.26M | Sell |
|
|||||
|
2021
Q1 | $9.55M | Hold |
|
|||||
|
2020
Q4 | $10.9M | Hold |
|
|||||
|
2020
Q3 | $9.35M | Buy |
|